US Stock MarketDetailed Quotes

CLNN Clene

Watchlist
  • 0.3720
  • 0.00000.00%
Trading May 21 09:32 ET
47.78MMarket Cap-907P/E (TTM)

About Clene Company

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Company Profile

SymbolCLNN
Company NameClene
Listing DateAug 27, 2018
Founded2013
CEOMr. Robert Etherington
MarketNASDAQ
Employees85
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6550 South Millrock Drive,Suite G50
CitySalt Lake City
ProvinceUtah
CountryUnited States of America
Zip Code84121
Phone1-801-676-9695

Company Executives

  • Name
  • Position
  • Salary
  • Robert Etherington
  • President, Chief Executive Officer and Director
  • 1.71M
  • Mark Mortenson
  • Chief Science Officer
  • 1.38M
  • Morgan R. Brown
  • Chief Financial Officer and Principal Accounting Officer
  • 993.70K
  • David J. Matlin
  • Chairman of the Board
  • 139.93K
  • Reed Neil Wilcox
  • Director
  • --
  • Alison H. Mosca
  • Independent Director
  • 123.39K
  • Shalom Jacobovitz
  • Independent Director
  • 121.93K
  • Jonathon T. Gay
  • Independent Director
  • 96.13K
  • Dr. Vallerie V. McLaughlin
  • Independent Director
  • 106.84K
  • Dr. Arjun JJ Desai, M.D.
  • Independent Director
  • --
  • Matthew Kiernan
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg